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PREFACE 
Before presenting the work performed during my PhD program my main aim is to 
thankthe people that believed in me since I started my experience in the Neuroscience 
field. Firstly, wish to thank my family, my mother and my brother because they followed 
me during this path, too hard to take on in some moments in which I really thought to 
leave everything for coming back to my old, boring and easier life. I couldn’t avoid to say 
thank you to my teacher Carla Cannizzaro because she is the first person that introduced 
me the neuroscience world, sharing with me her passion for the research.  In the last two 
years of my PhD program, I performed my research in NIDA laboratories, under the 
supervision of the Dr. Antonello Bonci. Even if my previous work dealt with the role of 
stress reaction in alcohol addiction, when I moved in NIDA I spent about four months in 
learning optogenetic, anatomical and immunohistochemistry tools that, coupled with my 
already assessed behavioral knowledge, could permit me to perform an independent 
experimental research. In order to do that I supported a Senior Post Doc, Ross  McDevitt, 
who, teaching me all these techniques, involved me in his project. This project coped with 
the characterization of Dorsal Raphe cell types responsible for reward processes. Even if 
we already published a paper on September 25, 2014” Serotonergic versus non-
serotonergic dorsal raphe projection neurons: differential participation in reward 
circuitry” we are still working on it. I was also involved in another project on Parkinson’s 
disease that copes with VGLUT2 role in the development of this pathology. In the last two 
months, looking forward my new path as post-doc in Bonci’s Lab, I launched a new 
project on VTA role on feeding and rewarding behaviors.  
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THE HETEROGENEITY OF VENTRAL TEGMENTAL AREA NEURONS: 
PROJECTION FUNCTIONS IN A MOOD-RELATED CONTEXT 
 Dopaminergic neurons of the ventral tegmental area (VTA) play a central role in reward 
learning (Wise, 2004). Midbrain dopamine neurons located in the VTA play also a key 
role in several disorders including schizophrenia, drug addiction and mood disorders such 
as depression (Marinelli and White, 2000, Krishnan et al., 2007, Cao et al., 2010, Valenti 
et al., 2011, Chaudhury et al., 2013, Friedman et al., 2014). Even if classically the VTA 
was thought to consist of dopamine (DA) neurons (Yim and Mogenson, 1980, Grace and 
Onn, 1989), studies have shown that while the majority of cells in the VTA are 
dopaminergic (~70%), there are also small percentages of both GABA (~30%) and 
glutamatergic (~2–3%) neurons in this region (Yamaguchi et al., 2007, Nair-Roberts et al., 
2008). Additionally, certain subpopulations of neurons have been shown to co-release two 
transmitters (Sulzer et al., 1998,Stuber et al., 2010, Tritsch et al., 2012). The advent of 
optogenetics has allowed for the dissection of neural circuits in both a cell-type and 
projection-specific manner (Lobo et al., 2010, Lammel et al., 2011, Chaudhury et al., 
2013, Tye et al., 2013). Further studies in non-human primates suggested that phasic 
activation of DA neurons was found to serve more in denoting the occurrence in reward 
related-stimuli than actually mediating the hedonic effects of reward (Schultz, 1998b). 
More specifically, recordings in non-human primates performing an operant task 
demonstrated that DA neurons could be activated by conditioned, reward predicting 
stimuli (Schultz, 1998a). Occurrence of reward in the absence of a conditioned stimulus 
(CS) induces phasic activation of DA neurons. Further, it was seen that when a CS 
predicted the occurrence of reward phasic firing was elicited immediately following the 
CS prior to the onset of the reward. Finally, phasic activation of DA neurons occurs 
following a CS, however, in the failure of a reward, DA neurons are depressed at texact 
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expected time of the reward. Initially, many in vitro slice recording experiments, 
performed both in mice and rats, suggested that VTA DA neurons were a homogenous 
population (Ungless et al., 2001, Argilli et al., 2008, Chen et al., 2008,Stuber et al., 2008). 
Early in vitro electrophysiological studies, performed in Sprague-Dawley rats, classified 
DA neurons of the VTA as the primary population of neurons (Grace and Onn, 1989, 
Schultz, 1998a). However, later studies note that other populations of cells also exist 
within the VTA, GABAergic, as well as glutamatergic neurons (Nair-Roberts et al., 2008). 
The neurochemical identities of all of these neurons still remain uncharacterized. 
GABAergic neurons within the VTA of Sprague-Dawley rats, exhibit a large amount of 
heterogeneity with a large range of action potential durations and firing rates. (Margolis et 
al., 2012). They constitute approximately 15–20% of the entire neuronal population 
(Margolis et al., 2012) and synapse onto both DA and non-DA VTA neurons (Bayer and 
Pickel, 1991,Omelchenko and Sesack, 2009). Similar to DA VTA neurons, GABAergic 
VTA neurons may also play diverse roles in behavioral responses. Some neurons in the 
VTA of both Sprague-Dawley rats and VGLUT1 kockout mice, express vesicular 
glutamate transporter 2 (VGLUT2), a marker of glutamatergic neurons, and are 2–3% of 
the total neuronal population, being located primarily in the rostro-medial portion of the 
VTA (Fremeau et al., 2004, Nair-Roberts et al., 2008). All cells contain glutamate for their 
role in protein synthesis, however, for exocytotic release, the VGLUTs are required 
(Reimer and Edwards, 2004, Takamori, 2006). The VTA projects to many regions 
including the NAc, mPFC, and the amygdala (Wise and Bozarth, 1985).  
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While it has been established that the VTA-to-NAc circuit is a crucial element in the 
pathogenesis of stress-related disorders, other areas, such as the mPFC and amygdala are 
also known to affect these behaviors. Notably, the mPFC both receives innervations from 
the VTA and sends projections to the VTA and NAc, forming a regulatory feedback 
mechanism (Nestler and Carlezon, 2006).  
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MORPHOLOGICAL AND NEUROCHEMICAL CHARACTERIZATION OF 
DORSAL RAPHE NUCLEUS 
Whole-brain mapping studies have found the greatest density of VTA-projecting neurons 
to reside in the dorsal raphe nucleus (DRN) (Phillipson, 1979; Watabe-Uchida et al., 
2012). The DRN contains the largest group of serotonin neurons in the brain, and supplies 
the vast majority of ascending serotonergic projections (Jacobs and Azmitia, 1992). The 
primary synaptic inputs within and to the raphe are glutamatergic and GABAergic. The 
DRN is divided into three subfields, i.e., ventromedial (vmDR), lateral wings (lwDR) and 
dorsomedial (dmDR). Although 5-HT neurons have similar physiological properties, 
important differences exist between subfields. Non-5-HT neurons are indistinguishable 
from 5-HT neurons. Glutamate neurons, as defined by vGlut3 anti-bodies, are intermixed 
and co-localized with 5-HT neurons within all raphe subfields. Finally, the dendritic arbor 
of the 5-HT neurons is distinct between subfields. Previous studies regard 5-HT neurons as 
a homogenous population. Understanding the interaction of the cell properties of the 
neurons in concert with their morphology, local distribution of GABA and glutamate 
neurons and their synaptic input, reveals a more complicated and heterogeneous raphe. 
These findings leave an open question: how specific subfields can modulate behavior? 
The role of the DRN in reinforcement learning is unclear, with literature suggesting both 
excitatory and inhibitory functions. For example, electrical stimulation of the DRN is 
sufficient to vigorously reinforce instrumental behavior in rats (Corbett and Wise, 1979; 
Margules, 1969; Rompre and Miliaressis, 1985; Simon et al., 1976; Van Der Kooy et al., 
1978). In contrast, drugs that selectively elevate levels of serotonin, the major 
neurotransmitter output of the DRN, possess very low abuse liability in humans and are 
not self-administered in laboratory animals (Gotestam and Andersson, 1975; Griffiths et 
al., 1976; Zawertailo et al., 1995).  
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A recent study provided evidence that optogenetic stimulation of serotonergic DRN cell 
bodies is capable of reinforcing instrumental behavior (Liu et al., 2014). However, a 
majority of the rewarding effects of electrical DRN stimulation act through fibers with 
refractory periods that are too rapid to be of serotonergic origin (Rompre and Miliaressis, 
1987). These studies suggest that the DRN contains a population of non-serotonergic 
fibers capable of reinforcing behavior to a greater degree than serotonin-producing 
neurons. However, it is not known whether these fibers originate from neurons within the 
DRN, or instead represent axons of distal cell bodies projecting to or through the DRN.  
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DOPAMINE ROLE IN REWARD FUNTION 
Several fine points continue to be discussed in the literature. Is dopamine absolutely 
necessary for reward? Is dopamine more important for the expectancy of reward or for the 
impact of reward after it is delivered? Is the dopamine in nucleus accumbens more 
important for reward than the dopamine in other brain regions? Some of these recent issues 
are best resolved by consideration of the early literature. Studies involving 
pharmacological blockade of dopamine receptors have suggested a necessary role for 
dopamine in the reward function (Wise & Rompre ́ 1989; Wise 2004). Dopamine is also 
important for the motivation to seek anticipated food or rather for the reinforcing effects of 
food once it has been earned and received (Berridge & Robinson 1998; Salamone & 
Correa 2002). Food rewards have both kinds of effect (Wise 1989, 2004).  Dopamine 
antagonists impair learning (Wise & Schwartz 1981) and, by extinguishing them, 
previously learned (Wise et al. 1978a,b) instrumental responding for food. Several lines of 
study confirm that they do so by blunting reward function itself (Wise 1982, 2004a; 
Beninger 1983; Smith 1995) rather than, as has been suggested (Mason et al. 1980; Koob 
1982; Tombaugh et al. 1982; Salamone 1986), by simply impairing performance capacity. 
The earliest evidence that dopamine plays an important role in motivational function was 
that brain stimulation and psychomotor stimulants were simply ineffective as reinforcers in 
animals treated with response-sparing doses of dopamine antagonists. Intravenous 
amphetamine and cocaine failed to maintain responding when tested under the influence of 
dopamine antagonists, despite evidence of adequate response capacity. Indeed, in this case 
animals respond at higher than normal rates before ceasing to respond following 
pretreatment with dopamine antagonists (Yokel & Wise 1975, 1976; de Wit & Wise 1977; 
Ettenberg et al. 1982). In the case of brain stimulation reward, responding is generally 
lower when animals are treated with dopamine antagonists; however, several conditions 
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reveal that the low response rates are due to ineffectiveness of the reinforcer and not 
incapacitation of the animal. First, responding decreases progressively, both within 
sessions and across sessions, in animals pretreated with dopamine antagonists (Fouriezos 
& Wise 1976; Fouriezos et al. 1978; Franklin 1978; Franklin & McCoy 1979).  
The concept of reinforcement is, at its core, a concept of how stimulus (Pavlov 1928) and 
response (Thorndike 1933) associations are formed and how they serve as the basis of 
habit acquisition (Skinner 1938). Food does not serve as a normal reinforcer in animals 
pretreated with dopamine antagonists; such treatment causes, for example, a dose-
dependent decrease in how quickly animals learn to lever-press for food (Wise & Schwartz 
1981). Under pretreatment with low doses of the dopamine antagonist animals eventually 
reach the normal performance asymptote; however, they require more trials to do so. With 
higher pretreatment doses learning is slower and may not reach the same performance 
asymptote. With yet higher doses there is no evidence of learning.  
While the concept of reinforcement is most frequently used to explain response learning 
(Thorndike 1933; Skinner 1935; Hull 1937), it was first used in relation to stimulus 
learning (Pavlov 1928). Stimulus learning is now known to contribute significantly to 
response learning (Rescorla & Solomon 1967; Bindra 1972) and dopamine is thought to 
play a role in both (Wise 1989). Most studies of the reinforcing efficacy of food reward 
deal with the ability of the reward to maintain rather than to establish instrumental 
behaviour; without reinforcement both stimulus associ ations (Pavlov 1928) and response 
associations (Skinner 1933) extinguish. When well-trained animals are tested under the 
influence of dopamine antagonists, food loses the ability to maintain normal responding. 
Whereas normal responding is initiated, responding slows progressively both within 
sessions and across sessions (Wise et al. 1978b; Dickinson et al. 2000). Similar 
progressive loss, both within and across trials, can be seen in the ability of food to 
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maintain free feeding ( Wise & Raptis 1986). The response slowing resembles what is seen 
in extinction conditions (when the normal reward is withheld), and is generally interpreted 
as a reflection of the impoverishment or ‘devaluation’ of food reward in the dopamine-
impaired animal (Wise et al. 1978a,b; Xenakis & Sclafani 1981, 1982; Geary & Smith 
1985). Few alternative hypotheses have been offered to explain the progressive response 
deficits seen when animals are tested under conditions of dopamine blockade. There is the 
suggestion that the progressive deficit might reflect a susceptibility to fatigue (or some 
other progressive within-trial performance impair- ment) caused by dopamine antagonists. 
This hypothesis can be ruled out from a variety of findings. First, the deficits are not only 
progressive within-trials; responding decreases progressively across repeated tests that are 
spaced days apart, with normal levels of responding between the days when the dopamine 
antagonist is given (Fouriezos et al. 1978; Wise et al. 1978b; Wise & Raptis 1986). 
Second, animals trained under intermittent dopamine blockade, like animals under 
intermittent reinforcement, respond more, not less, when tested for habit strength during 
extinction trials (Ettenberg & Camp 1986).  
 
 
 
 
 
 
 
 
 
 
11 
 
INVOLVEMENT OF VTA DOPAMINE NEURONS IN FEEDING AND 
REWARDING BEHAVIOR  
The lateral hypothalamus (LH) has long been implicated by lesion and  electrical 
stimulation studies in feeding and reward (Anand and Brobeck, 1951;  Olds, 1956; 
Margules and Olds, 1962; Hoebel, 1969). While the cells of the LH have been traditionally 
assumed to integrate feeding-related signals (Saper et al., 2002; Berthoud and Munzberg, 
2011), it has not been clear whether LH cells of origin or  medial forebrain bundle fibers of 
passage were responsible for the disruptions of  feeding and reward caused by lateral 
hypothalamic lesions (Ungerstedt, 1971; Stricker and Zigmond, 1974) or the induction of 
feeding and reward by electrical   stimulation (Ranck, 1975; Bielajew et al., 2000). Recent 
optogenetic studies have  now confirmed that activation of GABAergic projections to the 
VTA from LH cells of  origin is sufficient to induce feeding (Jennings et al., 2015; Nieh et 
al., 2015), food-seeking (Jennings et al., 2015; Nieh et al., 2015) and reward (Jennings et 
al., 2015). However, electrical stimulation studies indicate that stimulation   in the ventral 
tegmental area as well as in the lateral hypothalamus can induce both feeding and reward. 
Moreover, paired-pulse stimulation studies confirm that the reward and feeding involve 
fibers that connect the two regions and have similar refractory   periods, conduction 
velocities, and anatomical alignment within the medial  forebrain bundle (Shizgal et al., 
1980; Bielajew and Shizgal, 1982; Gratton and Wise, 1988a, b). These common 
characteristics could suggest (but do not confirm) that the same fiber population is 
involved in both effects. This suggestion fits with the optogenetic finding that both effects 
can be induced by activation of a GABAergic projection to the VTA (Jennings et al., 2015; 
Nieh et al., 2015). It is well established that DA has a crucial role in both compulsive drug 
and food seeking behaviors. Motivation and Reinforcing aspects are key components of 
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these behaviors but how are they dependent on modulation of dopaminergic system is still 
an open question.CertainlyLateral Hypothalamus (LH) can play a crucial role in the 
modulation of both compulsive drug and food seeking behaviors. Indeed, studies on 
experimental rodent models and humans have shown that stimulation of LH is rewarding 
(Olds J., 1958; Heath RG, 1972; Hess WR, 1957) since it is able to induce compulsive-like 
behavior.The absolute refractory periods for the fibers mediating LH brain stimulation 
reward and feeding range from 0.4 to about 1.2 msec (Yeomans JS, 1978-Wise R, 1988). 
Animals don’t show behavioral improvement when C-T pulse intervals are increased 
between 0.6 - 0.7 msec (Wise R,1988). It suggests that there are two populations of fibers: 
 VERY FAST (refractory periods between 0.4 - 0.6 msec) 
 SLOWER (RP ranging between 0.7 and 1.2 msec). 
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AIMS 
The goal of my PhD program was firstly to assess the characterization of Dorsal Raphe 
cell types responsible for reward processes and even if we already published a paper on 
September 25, 2014 ” Serotonergic versus non-serotonergic dorsal raphe projection 
neurons: differential participation in reward circuitry” we are still working on it. 
Particularly we explored the participation of these populations in reward circuitry and 
reinforcement learning. By testing self-stimulation behavior, anterograde/retrograde 
tracing, and electrophysiology, we found that the DRN reinforces behavior preferentially 
through non-serotonergic neurons, which make up the majority of the DRN-VTA pathway 
and produce strong glutamatergic excitation of VTA dopamine neurons. Nevertheless this 
already assessed information was for me and my work team a start point for the 
development of a new project that aims to clarify glutamate population role on reward 
circuitry and reinforcement learning  using  optogenetic approach  in two  cre-expressing 
transgenic mouse lines:SERT cre and Vglut 3 cre (project in collaboration with Ross 
McDevitt). Given that the DNR-VTA projection looks to be responsible of reward 
processes, in my mind are risen new open questions: 
 Is the LH-VTA gabaergic stimulation involved in compulsive or rewarding aspect 
of feeding? 
 Does the VTA act as a role player in feeding? 
 Can the compulsive and rewarding feeding be regulated by specific DAergic 
neuronal populations receiving distinct LH projections or by a cluster of DAergic neurons 
acting in a frequency dependent manner? 
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EXPERIMENTAL PROCEDURES OF DNR PROJECT 
Animals  
Adult (8+ weeks) male and female mice were housed with food and water available ad 
libitum. Mice were housed on a 12/12 hour light cycle with lights on at 7:00 AM. All 
experiments except intravenous self-administration were carried out during the animals’ 
light cycle. Wild-type C57Bl6/J mice were ordered from Jackson Laboratories (Bar 
Harbor, ME); transgenic mice were bred in-house. Transgenic expression of cre 
recombinase was achieved in serotonin neurons using ePet-cre (Scott et al., 2005) or 
Sl6a4cre/+ mice, referred to herein as SERTcre (Zhuang et al., 2005). ePet-cre mice were 
considered advantageous for behavioral experiments because SERTcre mice are 
heterozygous knockouts for the serotonin transporter, a manipulation that alters basal 
extracellular serotonin levels (Mathews et al., 2004) and could possibly confound 
behavioral data. Additionally, ePet-cre mice do not demonstrate ectopic cre expression 
during early development like the SERTcre line (Scott et al., 2005; Zhuang et al., 2005), 
and were therefore used to selectively induce recombination in serotonergic neurons for 
genetic fluorescent labeling. Dopaminergic and GABAergic neurons were targeted using 
THiCre/+ (Lindeberg et al., 2004) and VgatiCre/+ (Vong et al., 2011) mice. Deletion of 
serotonin synthesis was carried out in Tph2lox/lox mice (Wu et al., 2012). Cre-mediated 
fluorescence was produced using ROSA26fsTdTomato/+ mice, which carry a floxed stop 
cassette preceding a coding region for the TdTomato gene (Madisen et al., 2010). All lines 
were backcrossed onto a C57Bl6/J background. Mice were surgically injected with viral 
vectors and implanted with fiber optic cables (Britt et al., 2012b), the details of which are 
described in Supplemental Experimental Procedures. All animal procedures were approved 
by the National Institute on Drug Abuse’s animal care and use committee and carried out 
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in accordance with National Institutes of Health Guide for the Care and Use of Laboratory 
Animals.  
 
Optogenetic real-time place preference  
Mice were placed in a 24 × 36 cm plastic chamber with walls of opposite halves identified 
by horizontal or vertical stripes, and a small 0.5 cm barrier on the floor at the division site. 
A cohort of naïve wild-type mice tested in these chambers did not display a preference for 
either side (51.8 ±2.6% preference for horizontally-striped half; n=6). Mouse movement 
was tracked with Ethovision computer software (Noldus; Wageningen, Netherlands) and 
presence in the randomly-assigned laser-paired half resulted in 15 mW 473nm laser 
stimulation at 20 Hz, with 5 ms pulses. Mice remained in the chamber for 12 minutes. 
Electrical self-stimulation studies indicate that the reward substrate within the DRN is 
increasingly responsive to higher stimulation frequencies, with reward thresholds 
occurring within the range of 13–40 Hz, depending on electrode placement (Rompre and 
Miliaressis, 1985). ChR2 protein is capable of inducing action potentials in a variety of 
neuron types up to 20 Hz, above which spike fidelity is less reliable (Tye and Deisseroth, 
2012). Therefore in the present study, 20 Hz optogenetic stimulation was used to drive 
action potentials in serotonergic and non-serotonergic DRN cells. Although serotonergic 
DRN neurons typically have baseline firing rates below 5 Hz, they were recently shown to 
briefly fire at 20–30 Hz during a reward task (Liu et al., 2014). DRN serotonin neurons are 
capable of following extrinsic 20 Hz stimulation without entering depolarization block, as 
assessed with whole-cell patch clamp and in vivo microdialysis (Sharp et al., 1989).  
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Optogenetic nose-poke self-stimulation  
One week after the place preference task, mice were allowed to self-stimulate by 
performing a nose-poke instrumental response (Stuber et al., 2011). On a habituation day, 
mice were placed in operant chambers (Med Associates; St Albans, VT) for 45 minutes 
with ports closed off to prevent access. Mice were then given access to ports for 3 days of 
testing. Mice were placed in the chamber for 1 hour. A nose poke into the active port 
resulted in a 3- second train of laser pulses (30mW for midline DRN stimulation, 2 × 
15mW for bilateral VTA stimulation) at 20 Hz with 5 ms pulses, accompanied by 
dimming of the house light and an auditory cue. Nose pokes during the 3 second 
stimulation period had no consequence and were not counted towards the active nose poke 
total.  
Electrophysiology  
Details of procedures and recipes can be found in supplemental methods. Briefly, cells 
within 250 μm slices of tissue containing DRN or VTA were recorded in whole-cell patch 
clamp using a potassium gluconate-based internal solution. VTA dopamine cells were 
identified by morphology, tonic spike rate, and presence of a hyperpolarization-induced Ih 
current, which can be a reasonable predictor of dopaminergic identity in mice (Margolis et 
al., 2006; Wanat et al., 2008; Zhang et al., 2010). Cells were optically stimulated with 473 
nm laser light, directed at tissue through a fiber optic cable submerged in the bath and 
aimed at the region of interest.  
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RESULTS 
Pharmacological stimulation of dopamine but not serotonin release reinforces 
behavior  
A, Mice (n=9–18/group) were conditioned with injections of the serotonin-releasing agent 
fenfluramine (0–30 mg/kg, i.p.) or the dopamine-releasing agent amphetamine (1–3 
mg/kg, i.p.). B, Percent of time spent in drug-paired chamber on baseline and test days. 
Repeated measures ANOVA (drug x day) interaction F(7,96)=4.166, p<0.001; ** p<0.01, 
*** p<0.001 post-hoc. C, Change in time spent on drug-paired chamber between test and 
baseline days. One-way ANOVA F(7,96)=5.318, p<0.0001; * p<0.05, *** p<0.001 
Dunnett’s post-hoc vs. saline. D, Self-administration experiment in a separate cohort of 
mice. After pre-training for sucrose, mice were implanted with intravenous catheters and 
allowed to self-administer fenfluramine (0.03 mg/kg/infusion) or amphetamine (0.05 
mg/kg/infusion), n=8/group. E, Sample data from individual self-administration sessions 
demonstrating timing of infusions for mice with access to fenfluramine (red) and 
amphetamine (blue), and during the first day of extinction training. F,G, daily lever-press 
counts during sucrose pre-training (left Y axis) and drug self-administration (right Y axis). 
These experiment phases are plotted on different scales because the number of maximally-
allowed rewards differed. H, total number of lever presses during last three days of drug 
access. Two-way ANOVA (drug x lever) interaction F(1,28)=8.095, p<0.01; *** p<0.001 
post-hoc. I, Daily drug infusions during drug self- administration phase. J, total number of 
drug infusions during last three days drug access, ** p<0.01. K, Daily counts of infusions 
of saline during extinction training. L, total number of saline infusions during the first two 
days of extinction, * p<0.05. Group data are presented here and in subsequent figures as 
mean ± SEM.  
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Optogenetic stimulation of VTA dopamine but not DRN serotonin cell bodies 
reinforces behavior  
Selective targeting of gene expression was achieved by injecting cre-induced (“cre-ON”) 
vectors expressing ChR2-eYFP or eYFP alone into the (A) DRN of ePet-cre mice or (B) 
VTA of THiCre mice. Insets depict expression of eYFP (green), double-labeled in red with 
tryptophan hydroxylase (TpH) for DRN tissue or tyrosine hydroxylase (TH) for VTA 
tissue. Scale bars = 200 μm. C, Mice were trained to nose-poke into an active port to 
receive 3- second trains of 20 Hz laser stimulation; nose-pokes into an inactive port were 
not reinforced. D,E, Representative cumulative-activity graph and group mean nose-pokes 
made in first behavioral session for VTA-dopamine (n=11), DRN-serotonin (n=18), and a 
combined control group expressing eYFP in DRN or VTA (n=17). Two-way ANOVA 
(group x port) interaction F(2,86)=8.317, p<0.001; *** p<0.001 post-hoc. F, Active nose 
poke responding on three consecutive days of testing. G, Mice underwent a real-time place 
preference task in which presence in one half of a chamber triggered continuous 20 Hz 
laser stimulation. Example tracks for a DRN serotonin stimulated mouse (top; red) and a 
VTA dopamine stimulated mouse (bottom; blue). H, Minute-by-minute percent of time 
spent in the laser-paired half of the chamber. I, Overall preference for laser-paired side 
during 12- minute session. One-way ANOVA F(2,38)=12.05, p<0.0001; ** p<0.01, *** 
p<0.001 post- hoc. J, Percent of laser pulses in a 20 pulse train resulting in action 
potentials in ChR2+ DRN serotonin cell bodies, recorded ex vivo in whole-cell current 
clamp. Inset, sample trace with 20Hz stimulation. See also Figures S1 and S2.  
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Optogenetic stimulation of DRN cell bodies reinforces behavior in a dopamine- 
dependent, serotonin-independent manner  
A, Left panel, schematic view of a cell transduced with cre-induced (“cre-ON”) viral 
vector. In the absence of cre recombinase, viral plasmid DNA remains in antisense 
orientation and does not express functional protein. Inset, lack of eYFP signal in mouse 
injected with cre- ON ChR2-eYFP. Right panel, co-injection of cre-ON and cre-expressing 
viral vectors results in knockout of floxed genomic DNA and rearrangement of viral 
plasmid DNA into sense orientation, resulting in expression of ChR2-eYFP. Inset, robust 
eYFP expression in mouse co-injected with cre-expressing and cre-ON viral vectors. B, 
Tph2lox/lox mice were co-injected with viral vectors expressing cre and cre-ON ChR2-
eYFP or eYFP into DRN. Insets, whole DRN (scale bar = 200 μm) and detail of non-
overlapping expression of eYFP (green) and tryptophan hydroxylase (TpH, red). Thus, 
cells with ChR2 lack the enzyme necessary for serotonin synthesis. An additional 
anatomical control group was co-injected with cre and cre-ON ChR2 0.7mm anterior to the 
DRN. C, Nose pokes during first day of self-stimulation testing for non-serotonergic DRN 
stimulation (n=10), anterior controls (n=8), and eYFP controls (n=7). Two-way ANOVA 
(group x nose port) interaction F(2,44)=4.482, p<0.05; ** p<0.01 post-hoc. Inset, active 
nose pokes on 3 consecutive days of testing. D, Percent of time spent on laser side in a 
real-time place preference task. One-way ANOVA F(2,22)=11.24, p<0.001; ** p<0.01, 
*** p<0.001 post- hocs. E, Non-serotonin DRN stimulated mice (n=6) were tested for 
nose-poke optical self-stimulation 30 minutes after injection of vehicle or 5-
hydroxytryptophan (5-HTP; 40 mg/kg i.p.), the intermediate in the serotonin synthesis 
pathway. 5-HTP is the product of the enzyme tryptophan hydroxylase, which is knocked 
out in ChR2-positive cells of these mice. F, Cumulative- activity graph of nose pokes in 
test sessions after injection of vehicle or 5-HTP. Individual data points were normalized to 
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percent of nose pokes achieved during a 30-minute baseline session on day 1. G, Non-
serotonin DRN stimulated mice (n=6) were tested after injection of the dopamine D1 
receptor antagonist SCH23390 (SCH; 30 μg/kg, i.p.) at either 15 or 30 minutes before 
testing. H, Cumulative-activity graph of active nose pokes in 30-minute sessions following 
injection of saline or SCH. I, Active nose pokes during 5-minute bins at the beginning or 
in the middle of test depicted in panel H. Individual data points were normalized to percent 
of responses during baseline day. Repeated-measures ANOVA (drug x epoch) interaction 
F(2,15)=4.560, p<0.05; *** p<0.001 Dunnett’s post-hoc vs saline. See also Figures S3 and 
S4.  
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Optogenetic stimulation of dopaminergic or GABAergic DRN cell bodies fails to 
reinforce nose-poke self-stimulation  
A, DRN dopamine neurons were targeted by injecting cre-induced (“cre-ON”) vectors 
expressing ChR2-eYFP (n=10) or eYFP (n=14) into the DRN of THiCre mice. Inset 
shows eYFP (green) double-labeled with tyrosine hydroxylase (TH, red). B, Nose 
pokes in the first day of testing. C, Active nose pokes on three consecutive days of 
testing. D, Percent of time spent on laser side in real-time place preference task. E, 
DRN GABA neurons were targeted by injecting cre-ON ChR2-eYFP (n=8) or eYFP 
(n=4) into the DRN of VgatiCre mice. Inset shows eYFP (green) cell bodies in the 
lateral DRN, which do not co-label for serotonin (5- HT, red) or tyrosine hydroxylase 
(TH, blue). Laser stimulation did not reinforce nose poke self-stimulation (F,G) but did 
induce a real-time place preference (H), p<0.05. Scale bars = 200 μm.  
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Unlike serotonergic neurons, non-serotonergic DRN neurons preferentially project 
to the VTA  
A, Schematic of cre-silenced (“cre-OFF”) DNA construct containing loxP-flanked 
ChR2- eYFP coding region. B, Transduction of primary cultured rat neurons with cre-
OFF ChR2- eYFP viral vector produces eYFP fluorescence (left) that is abolished in 
cells co-transduced with a vector expressing cre recombinase (right); DAPI nuclear 
staining (blue) is unaffected. Scale bar = 100 μm. C, Transgenic mice co-expressing cre 
and TdTomato inserotonergic neurons (ePet-cre; ROSA26fsTdTomato, n=4) were 
injected with cre-OFF ChR2-eYFP into the DRN. Inset depicts whole DRN tissue 
(scale bar = 200 μm) and detail demonstrating segregation of TdTomato and eYFP 
fluorescence into separate populations of cells. D, Serotonergic (red) and non-
serotonergic (green) axons are visible in the VTA, identifiable by tyrosine hydroxylase 
immunoreactivity (TH, blue). Scale bar = 200 μm. E,F Quantitation of (E) eYFP and 
(F) TdTomato fluorescence intensity in brain regions with conspicuous eYFP 
expression. Abbreviations: ventral tegmental area (VTA), substantia nigra pars 
compacta (SNc), intermediate portion of the lateral septum (LSi), bed nucleus of the 
stria terminalis (BNST), red nucleus (RN), interpeduncular nucleus (IPN), nucleus 
accumbens (NAc), dorsal portion of the lateral septum (LSd), substantia nigra reticulata 
(SNr), prefrontal cortex (PFC). 
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The majority of DRN cell bodies that project to VTA are non-serotonergic  
 
The retrograde tracer Fluoro-Gold was iontophoretically infused into the (A) VTA or (B) 
substantia nigra reticulata (n=4/group). Left panels, Fluoro-Gold (green) at infusion site, 
double-labeled with tyrosine hydroxylase (TH) to label dopamine neurons (red). Right 
panels, retrograde-labeled cells in DRN, double-labeled with tryptophan hydroxylase 
(TpH) to label serotonin neurons (red). Scale bars = 200 μm. C, Number of Fluoro-Gold-
labeled cells in DRN tissue from mice injected with Fluoro-Gold in VTA or substantia 
nigra reticulata. Fluoro-Gold cells were grouped by presence or absence of tryptophan 
hydroxylase double-label (TpH+, TpH−). Two-way ANOVA (region x TpH label 
interaction) F(1,12)=34.11, p<0.0001; *** p<0.001 post-hoc. D, Percent of Fluoro-Gold 
labeled cells double-labeling for tryptophan hydroxylase. *** p<0.0001. E, Number of 
TpH − (left) and TpH+ (right) Fluoro-Gold labeled cells across the rostrocaudal axis of the 
DRN. X-axis indicates location of DRN tissue, in millimeters posterior to bregma.  
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DRN-VTA projections reinforce behavior and provide synaptic glutamatergic 
excitation of VTA dopamine neurons primarily via non-serotonergic projections  
A, Mice (n=11) were injected with non-specific ChR2 viral vector in the DRN, and 
implanted with fiber optic cables in the VTA. B, Cumulative activity-graph of nose 
pokes into active and inactive ports on the first day of training. Total number of 
responses was greater into the active port (p<0.01). C, Total number of active nose 
pokes on day 1 from DRN-VTA mice. For comparison, data is reconstituted from 
previous experiments stimulating serotonergic and non-serotonergic DRN cell bodies. 
D, Serotonergic and non- serotonergic DRN projections were targeted by injecting cre-
induced (“cre-ON”) (n=6) or cre-silenced (“cre-OFF”) (n=4) vectors expressing ChR2-
eYFP in SERTcre mice. E, Representative voltage-clamp traces of VTA dopamine 
neurons showing optically-evoked glutamatergic excitatory post-synaptic current 
(EPSC) resulting from stimulation of terminals of the serotonergic (top trace) or non-
serotonergic (bottom trace) DRN-VTA pathway. F, EPSC amplitudes in response to 
optical stimulation. Graph includes cells that did not respond to light (plotted as 0 pA). 
G, Average amplitude of light-responsive EPSCs, ***, p<0.0001. H, Representative 
current-clamp traces of a VTA dopamine neuron spiking in response to 20 Hz laser 
stimulation of DRN-VTA serotonin (left) or non-serotonin (right) pathways. I, 
Individual spike fidelity measurements; represented as percent of laser pulses during a 
0.5 second, 20 Hz train that resulted in action potentials. J, Average spike fidelity in 
cells that responded to light with at least one action potential, p<0.05.  
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DISCUSSION 
In the present study we found that stimulation of DRN cell bodies was capable of strongly 
reinforcing instrumental behavior, with a level of vigor comparable to direct stimulation of 
VTA dopamine neurons. Although serotonergic neurons are the largest population of 
projection neurons in the DRN, selective stimulation of these cells did not reinforce 
behavior. Rather, self-stimulation was preferentially elicited by targeting non-serotonergic 
DRN neurons, which we showed to comprise the majority of DRN-VTA projections. 
Furthermore, stimulation of the DRN-VTA pathway was sufficient to fully reinforce 
instrumental learning. Because self-stimulation was not supported by DRN dopaminergic 
or GABAergic cell bodies, our observations suggest that the rewarding effects of DRN 
stimulation are mediated by non-serotonergic glutamate neurons. Accordingly, in vitro 
stimulation of the non-serotonergic DRN-VTA pathway increased VTA dopamine neuron 
firing rates and produced monosynaptic glutamatergic currents that were substantially 
larger than those elicited by stimulating the serotonergic pathway. The DRN contains the 
largest group of serotonergic neurons in the brain, a subset of which encode information 
about magnitude of reward received (Inaba et al., 2013; Liu et al., 2014; Nakamura et al., 
2008). We employed a variety of optogenetic and pharmacological methodologies to test 
the possibility that such activity drives reinforcement learning. In all cases, the results of 
our experiments did not support this conclusion. This is consistent with reports that rats 
and primates do not self-administer serotonergic drugs (Gotestam and Andersson, 1975; 
Griffiths et al., 1976), which we now extend to mice. In both fenfluramine and optogenetic 
place preference experiments, maximal trends towards rewarding effects were seen at low 
doses/frequencies, suggesting that serotonin may exert pro-reward effects in an inverted-U 
shaped manner. A recent study demonstrated that optogenetic stimulation of serotonergic 
DRN neurons in mice can reinforce a variety of instrumental tasks (Liu et al., 2014). There 
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were several methodological differences between this study and our present work that 
likely afforded Liu et al greater sensitivity in detecting behavioral effects of laser 
stimulation which, in our experiments, produced non-significant trends toward the same 
direction of effect. Nevertheless, using identical behavioral and optical parameters across 
experiments, we found that reinforcement learning was preferentially supported in this 
region by a population of non-serotonergic neurons. Mice in our study vigorously nose-
poked for optogenetic stimulation of non-serotonergic DRN neurons. This finding is 
consistent with reports that rats will respond for electrical DRN stimulation in a serotonin-
independent manner (Margules, 1969; Rompre and Miliaressis, 1987; Simon et al., 1976) – 
but see (Van Der Kooy et al., 1978). Although electrical self-stimulation literature 
provides the foundation for our understanding of brain reward circuitry, interpretation of 
this work is inherently limited by the fact that electrical stimulation of brain tissue excites 
both cell bodies and axonal fibers. In fact, action potentials are preferentially induced in 
axons, due to a far greater surface density of sodium channels (Nowak and Bullier, 1998). 
This issue is of particular importance because the DRN is bordered by dense fiber tracts; 
furthermore, it receives strong projections from several brain regions which are each 
individually sufficient to support reward learning, including the lateral hypothalamus, 
laterodorsal tegmental nucleus, and medial prefrontal cortex (Britt et al., 2012a; 
Kempadoo et al., 2013; Lammel et al., 2012; Lee et al., 2003). By using optogenetic 
methodology, we are able to negate the influence of stimulating fibers and localize the 
reward-relevant neuronal cell bodies.  
Electrical mapping studies indicate that rewarding sites in the brain are not restricted to the 
DRN, but extend rostrally in a continuous band before bifurcating laterally and merging 
with the VTA (Rompre and Miliaressis, 1985). We found that stimulation of cell bodies 
rostral to the DRN did not produce behavioral measures of reward, although we did 
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observe efferent fibers of DRN neurons in an identical pattern to the rewarding region 
described. Thus, the rewarding effects of electrical stimulation in this region are likely 
mediated by activation of axonal fibers originating from non-serotonergic cell bodies in 
the DRN. Furthermore, two-electrode collision experiments within this region suggest that 
the reward- relevant axons are highly branched between VTA and DRN (Boye and 
Rompre, 1996), suggestive of the dense network of non-serotonergic fibers that we 
observed in the VTA. The rewarding properties of DRN stimulation were dependent upon 
dopamine receptor activation. Although the DRN contains dopaminergic cell bodies 
(Dougalis et al., 2012; Lu et al., 2006), stimulation of these cells did not evoke reward-
related behavior, suggesting action on mesolimbic dopamine circuitry. Accordingly, we 
found that non-serotonergic DRN neurons primarily project to the VTA, with 
comparatively sparse projections to the nucleus accumbens and other forebrain structures. 
Furthermore, stimulation of the DRN- VTA pathway was sufficient to fully reproduce the 
rewarding effects of DRN cell body stimulation. Although other projection targets may 
contribute, these findings suggest that the DRN is capable of driving reinforcement 
learning primarily through its projection to the VTA. Because individual stimulation of 
serotonergic, GABAergic, and dopaminergic DRN cell bodies failed to reinforce behavior, 
we infer that the rewarding effects seen in our non- serotonergic stimulation experiment 
were mediated through a distinct population of cell bodies. The largest remaining 
population of cells, accounting for approximately 10% of DRN neuronal cell bodies, are 
non-serotonergic neurons expressing vesicular glutamate transporter 3 (Commons, 2009; 
Hioki et al., 2010). Indeed, we observed that stimulation of the non-serotonergic DRN-
VTA pathway produced strong monosynaptic glutamatergic currents and drove spiking 
activity in VTA dopamine neurons. Comparatively weak currents were observed following 
stimulation of the serotonergic DRN-VTA pathway. Because direct excitation of VTA 
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dopamine neurons is sufficient to powerfully reinforce instrumental learning (Witten et al., 
2011), it seems reasonable to propose that the rewarding effects of non-serotonergic DRN 
stimulation were driven, at least in part, by a glutamatergic DRN- VTA mechanism. 
However, the DRN is also noted to contain several peptidergic cell types, including 
corticotropin-releasing factor and substance P (Valentino and Commons, 2005). Although 
these peptides are aversive when administered intracerebroventricularly (Cador et al., 
1992; Elliott, 1988), we cannot rule out the possibility that these or other DRN cell types 
contribute to reinforcement learning. With these caveats in mind, the most parsimonious 
interpretation of the data presented is that this population of non-serotonergic glutamate 
neurons is highly efficacious in driving reward-related behavior. It has been shown that the 
DRN sends projections to mesolimbic circuitry, with the VTA receiving notably stronger 
innervation than nucleus accumbens (Vertes, 1991). Retrograde studies mapping whole-
brain inputs to the VTA have noted the DRN as a major input (Geisler et al., 2007; 
Phillipson, 1979; Watabe-Uchida et al., 2012). None of these reports, however, examined 
the serotonergic composition of this projection. Early studies of DRN anatomy led to the 
view that nearly all of its projection neurons are serotonergic (reviewed in Jacobs and 
Azmitia, 1992). We have quantitatively compared the composition of the DRN-VTA 
projections using anterograde, retrograde, and electrophysiological techniques. All three 
approaches supported the same conclusion: the majority of this pathway consists of non-
serotonergic projections. Our study raises important questions and open new avenues of 
investigation with respect to the role of this circuit in normal function and disease states. 
However we have preliminary data showing that VGLUT3 expressing neuron stimulation 
is responsible for rewarding effect. 
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 Since October 2015, I started a new indipendent project that aims to clarify VTA DA 
neuron involvement on feeding and reward. Even if I’m at very beginning of this way, I 
already got some preliminary data that I have the pleasure to share with you. My 
experimental design is very simple, I just used DAT-cre mice injected with DIO ChR2 and 
fibers in VTA. 
These mice underwent two experimental tests. 
1. Self-photostimulation: 
Analysis of nose-pokes self administration under increasing range of photostimulation 
frequencies.  
2.Food seeking behavior:  
Analysis of latency to approach the food and the time spent in the food zone throughout 
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the spatial location heat map with different frequency of photostimulation (5-10-20 and 40 
Hz). 
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MATERIALS AND METHODS  OF VTA PROJECT ON FEEDING AND 
REWARD 
Animals   
 A total of 4 male DAT-IRES Cre mice were used in this study. Mice (weighing 20-30 g at 
the start of experiments) were   housed in an animal vivarium maintained on a direct 12-h 
light-dark cycle (lights on at 7:00 am) and at a constant temperature of 23°C. They were 
kept undisturbed at  least one week before the start of any experimental procedure and 
were handled and weighed daily in order to minimize handling stress during experiments. 
Food and water were provided ad libitum except during experimental sessions. Animal 
care and use were in accordance with institutional and international standards (National 
Research Council, 2011) and were approved by the National Institute on  Drug Abuse 
Animal Care and Use Committee. All experiments were performed during the light phase 
of the diurnal cycle.   
Surgical and intracerebral infusion procedures  
 Each mouse was anesthetized with 1-5% isofluorane, placed in a stereotaxic  frame and 
the skull was exposed and leveled. Cre-inducible adeno-associated virus (AAV, serotype 
1) coding for the light-sensitive protein channelrhodopsin-2 (ChR2) and enhanced yellow 
fluorescent protein (eYFP) or for eYFP alone, under control of  the EF1α promoter were 
employed (NIDA IRP OTTC, Baltimore, MD). AAV1-EF1α- DIO-hChR2(H134R) -eYFP 
(ChR2 mice) was bilaterally injected into the VTA. The stereotaxic coordinates were: AP: 
-3,6 ML: ±1.6,  DV: -4,9. Injections of 500 nl per side were made with a flow rate of 100 
nl/min.  Infusions were done using an UltraMicroPump with Micro 4 controller, 10 μl 
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Nanofil syringes and 35 G needles (WPI Inc., Sarasota, FL). The needle was left in place 
for additional 5 min to prevent reflux. Simultaneusly viral infusions, each mouse received 
twointracranial optic fiber (200 μm diameter, BFL37-200, Thorlabs, Newton, NJ) for VTA 
directed just dorsal to VTA. One or two stainless-steel screws and dental acrylic cement 
were employed to anchor optic the fiber to the skull. Animals were given the analgesic 
meloxicam (0.2 mg/kg) to prevent post-surgical pain or discomfort and were allowed at 
least 30 days of recovery before the beginning of any experimental manipulation. Body 
weight was measured daily after surgery.   
Behavioral studies  
Apparatus 
 Feeding studies were conducted in acrylic chambers (34 x 25 x 19  150 cm) containing 
regular bedding. 
 Optical intracranial self-stimulation (oICSS) studies were conducted in sound-attenuated 
operant chambers (Med Associates, St. Albans City, VT) equipped with two operant 
response levers, a house light and a cue light  situated between the two levers. The system 
was monitored by MedPC software. Fiber optic cables were attached via FC/PC 
 connector to 473 nm lasers (OEM/Opto Engine LLC, Midvale, UT) for photostimulation. 
  
Feeding studies 
 ChR2 mice were habituated to the testing environment for three days before any 
experimental manipulation. On a given testday, each mouse was connected to a fiber optic 
cable and was placed in a chamber  with a pre-weighed amount of food scattered in a cup 
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located in the corner of the chamber. Each session lasted 40min and was divided into ten 
120-sec trials. During odd-numbered trials, the laser stimulation remained off for 120-sec. 
During even-numbered trials, continuous laser stimulation was given in 10msec pulses 
with laser intensity at the end of the fiber optics cable adjusted to 8 mW. Stimulation-
induced feeding was assessed at four stimulation frequencies—5, 10, 20 and 50 Hz—on 
separate days and balanced sequence. Latency to start eating and amount eaten were 
recorded for each trial. Latency to pick up and bite cardboard or food and weights of  the 
cardboard and food before and after testing were recorded.  
 
Optical intracranial self-stimulation studies 
ChR2 mice were  connected to the fiber optic cable and laser, and were placed in operant 
chambers equipped with two response levers (left and right) for daily 30-min self-
stimulation testing. During the training each session (60 minutes) began with illumination 
of the house light, which remained on for the entire session. A lever press (“active” lever) 
activated a cue light above and caused a 2-sec train of 33,3 Hz photostimulation (10mW, 
10 ms) followed by a 3 sec “time-out” during which stimulation was not available. The cue 
light remained illuminated until the end of the time-out. Responses on the other 
(“inactive”) lever were not rewarded. During the first 4 days of training, the rightlever was 
designated as the active lever; on day 5 and 6 the left inactive lever was introdused and the 
cue was removed. 
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 After 6 days of training at 33,3Hz, mice were tested daily at 8 frequencies (No laser, 1, 2, 
2.5, 3.7, 5.55, 8.33, 12.5, 20, 33.3, and 50 Hz). Each session was formed by 10 trials of 10 
minutes, in which we tested one frequency for time in decreasing order.During the first 
four days the stimulation was bilateral then I switchedwith unilateral, but unlucky I missed 
an animal during the experiment. Obviously I didn’t do any statistical analysis on this staff 
because I have just a very small animal group and I need to compare the results with a 
control group injected with DIO ChR2 in LH and fibers in VTA. I already did all the 
stereotaxic surgeries but I’m still waiting for the expression of the virus. Nevertheless, 
these preliminary data show that the favorite frequencies for the reward are the highers.  
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Stimulating the VTA DA neurons I didn’t see any feeding behavior and just a very small 
effect on locomotion was observed, how the following data show.  
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At this point my hypothesis is that DA cells in VTA are not involved in feeding and as 
consequence I wish to investigate the role of glutamatergic and gabaergic neurons on this 
behavior.  
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